News & Events

Cydan is a collaborative team of scientists and entrepreneurs experienced in orphan drug development.

Cydan is a collaborative team of scientists and entrepreneurs experienced in orphan drug development.

Press Releases


November 17, 2016

Vtesse Announces Dosing of First Patient in Germany for Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease

Clinicians Continue to Enroll Children with NPC at Trial Sites in France, Spain,
Turkey, the United States and the United Kingdom -- Expansion to Australia Expected Soon

Learn More

See All

Events


See All

In The News


See All